The use of new technologies (AI, High-throughput screening) in drug discovery has created an unprecedented backlog of drug candidates in parallel to the increasing importance and success of biologics. The pressure to bring medicines to the patient faster increases the need to accelerate R&D and make tech transfer to manufacturing more efficient. The pressure to bring these innovative medicines to patients more quickly has intensified the need to streamline research and development (R&D) processes and improve the efficiency of technology transfer to manufacturing. Companies must focus on enabling faster and more efficient scale-ups from the pre-clinical phase through clinical trials and into commercial manufacturing. How do we harness the technologies available today to speed up product commercialization through Tech Transfer into Manufacturing? Key areas for discussion will include the following:

• How organizations approach digital transformation and key challenges and successes encountered along the way.
• Best practices that can contribute to a successful and fast implementation.
• Tech Transfer technologies/New Product Introductions from R&D to Manufacturing.